title: Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
authors.affiliation: Memory Pharmaceuticals, 100 Philips Parkway, Montvale, NJ 07645, USA. info@memorypharma.com
authors.forename: Axel
authors.initials: A
authors.lastname: Unterbeck
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D035843:Biomedical Research; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy*; D004345:Drug Industry; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
chemical_list: D002491:Central Nervous System Agents; D010726:Phosphodiesterase Inhibitors